Olsar (40Mg) contains following Salts:-
Hydrochlorothiazide - Drug Information
Typical usage: :Disorders of calcium balance, Edema, Heart failure, Hypertension, Oedema, and can also be given in adjunctive therapy as an alternative drug of choice in Diabetes insipidus.
Probable Side Effects: :Dizziness, Thirst, Headache, Nausea, Gout, Impotence, Polyuria, Night cramps.
Drug Interaction: None mentioned.
Mechanism of Action: Hydrochlorothiazide, a thiazide diuretic, inhibits water reabsorption in the nephron by inhibiting the sodium-chloride symporter (SLC12A3) in the distal convoluted tubule, which is responsible for 5% of total sodium reabsorption.
Pregnancy Impact: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
Impact During Lactation: There are no controlled studies in breastfeeding women, however the risk of untoward effects to a breastfed infant is possible; or, controlled studies show only minimal non-threatening adverse effects. Drugs should be given only if the potential benefit justifies the potential risk to the infant.
Olmesartan - Drug Information
Typical usage: :Essential hypertension.
Probable Side Effects: :Dizziness, headache, abdominal pain, dyspepsia, diarrhoea, gastroenteritis, nausea, hypotension, peripheral oedema, haematuria, UTI, hyperkalaemia, hypertriglyceridemia, hyperuricaemia, elevated liver enzymes, facial edema, angioedema, and rhabdomyolysis.
Drug Interaction: Concurrent use with ACE inhibitors, potassium-sparing diuretics, potassium salts, and drugs that may increase serum potassium (e.g. ciclosporin, eplerenone) may increase the risk of hyperkalaemia. Concomitant use with NSAIDs may decrease glomerular filtration synergistically; acute renal failure may occur. Increased serum concentrations of lithium and toxicity when used with angiotensin receptor antagonist have been reported; avoid concomitant use of lithium and Olmesartan medoxomil.
Mechanism of Action: Olmesartan medoxomil is an ester prodrug for olmesartan. It is hydrolysed to olmesartan during absorption from the GI tract. Olmesartan is a selective and competitive angiotensin II Type 1 (AT1) receptor antagonist and hence it blocks the vasocontrictor and aldosterone-secreting effects of angiotensin II.
Pregnancy Impact: There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Impact During Lactation: There is positive evidence of risk to a breastfed infant or to breastmilk production, but the benefits of use in breastfeeding mothers may be acceptable despite the risk to the infant (e.g. if the drug is needed in a life-threatening situation or for a serious disease for which safer drugs cannot be used or are ineffective).
Price of Olsar (40Mg) : Rs.117.00
|Dispatches by||Next Day|
|Composition||Hydrochlorothiazide 12.5 mg, Olmesartan 40 mg|
|Salt Information||Hydrochlorothiazide, Olmesartan|
|Pack Size||10 Tablet|
Use spaces to separate tags. Use single quotes (') for phrases.
FAQ on Olsar (40Mg)
There are no product questions yet.
We guarantee to ship your order next day after order has been submitted
Please contacts us and our customer service team will answer all your questions
If you are not satisfied with your order - send it back within 14 days after day of purchase!
Substitutes of Olsar (40Mg)
Rs.1.00Cyper Drugs & Pharma
Rs.1.00Orchid Chemicals & Pharma
Rs.1.00Low Cost Standard Therapeutics (Locost)
- Mail Today
- Bio Spectrum
- The Financial Chronicle
- Business Standard
- News Informer
- Business Standard
- News Prelease
- Biznews Index
- 15 Minute News
- Biz Radar
- VNI India
- Khari News
- Hunt News
- Express Pharma
- Silicon India
- The Hindu
- Your Story
- Stratos Invest
- EPL India
- Hindustan Times
- The Times of India